Course Leader: MIKE WEBB, PH.D.Founder and CEO at Mike Webb Pharma

Mike Webb PhD was the VP of Development Chemistry and Analysis for GSK in the UK and was heavily involved in developing GSK’s oligonucleotide pipeline. Since leaving GSK in 2016 he has been consulting with Big Pharma and Biotechnology companies in the development, analysis and manufacture of therapeutic oligonucleotides from pre-clinical to marketing submission.

2022 SCHEDULE

Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides from Early Development to Registration

May 3-5, 2022

Course Time:

US attendees: May 3-5, 2022 from 12:00pm-2:30pm EST / 9:00am-11:30am PST

European attendees: 5:00pm-7:30pm British Summer Time BST/ 6:00-8:30pm CET

Sep 6-8, 2022

Course Time:

Japan Attendees: 3:00pm-5:30pm JST

European Attendees: 7:00am-9:30am British Summer Time BST/ 8:00am-10:30am CET

Nov. 8-10, 2022

Course Time:

European Attendees: 3:00pm-5:30pm British Summer Time BST/4:00-6:30pm CET

US attendees: 10:00am-12:30pm EST / 7:00am-9:30am PST